Go to deals

Mosaic Laboratories has been acquired by Caprion HistoGeneX

The shareholders of Mosaic Laboratories have sold the company to Caprion HistoGeneX.

Founded in 2005 by Lisa Dauffenbach and Chris Kerfoot, Mosaic Laboratories is a Lake Forest, California-based leading provider of bio-analytical testing services supporting translational, preclinical and clinical trial studies for a marquee roster of biotech and pharmaceutical clients globally. Mosaic pioneered proprietary multiplex immunohistochemistry (IHC) services that provide a superior ability to evaluate multiple biomarkers in a single tissue section, and has built a reputation among pharmaceutical companies to produce the most vivid IHC biomarker images. Mosaic supports the most rigorous clinical trial programs in the world, thereby impacting the future of patient therapies for cancer and other diseases.

Caprion HistoGeneX is a provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company operates two proprietary immune monitoring platforms that offer multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses while its proteomics business unit, as well as gel-free, label-free mass spectrometry (MS), provide comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Oaklins’ team in Los Angeles acted as advisor to the seller in this transaction.

M&A sell-side

Talk to the deal team

 Adam  Abramowitz

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Dolmen Engineering has been acquired by NIRAS
Construction & Engineering Services | Healthcare

Dolmen Engineering has been acquired by NIRAS

The private shareholders of Dolmen Engineering have sold the company to NIRAS. The integration will enable the two companies to strengthen their positions within the European life science and food & beverage sectors and offer a fully integrated suite of services.

Learn more
InMedica has acquired J. Pauliuko šeimos klinika
Private Equity | Healthcare

InMedica has acquired J. Pauliuko šeimos klinika

InMedica, the largest Lithuanian network of medical clinics, has acquired J. Pauliuko šeimos klinika.

Learn more